RIGEL PHARMACEUTICALS INC short interest in 2020
In 2020, RIGEL PHARMACEUTICALS INC's disclosed short interest ran from 6.40% of shares outstanding on 15 Jan 2020 to 12.81% on 31 Dec 2020, a change of +6.41 percentage points. The year's high was 14.45% on 30 Oct 2020 and its low 5.08% on 31 Jul 2020, averaging 9.53% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.20 days on 15 Apr 2020. Full history: RIGEL PHARMACEUTICALS INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 6.40% (15 Jan 2020)
- End of year
- 12.81% (31 Dec 2020)
- Change
- +6.41 pp
- High
- 14.45% (30 Oct 2020)
- Low
- 5.08% (31 Jul 2020)
- Average
- 9.53%
- Highest days to cover
- 19.20 (15 Apr 2020)
- SEC filings marked
- 9
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 6.40% | 6.31 | results (8-K) |
| 31 Jan 2020 | 9.13% | 7.60 | |
| 14 Feb 2020 | 9.34% | 15.20 | |
| 28 Feb 2020 | 9.17% | 14.45 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 9.09% | 10.72 | |
| 31 Mar 2020 | 9.05% | 11.89 | |
| 15 Apr 2020 | 9.11% | 19.20 | |
| 30 Apr 2020 | 8.68% | 6.19 | |
| 15 May 2020 | 8.74% | 12.01 | 10-Q filed, results (8-K) |
| 29 May 2020 | 8.72% | 11.28 | |
| 15 Jun 2020 | 8.67% | 10.16 | |
| 30 Jun 2020 | 9.01% | 6.29 | |
| 15 Jul 2020 | 9.09% | 1.00 | |
| 31 Jul 2020 | 5.08% | 1.48 | |
| 14 Aug 2020 | 5.87% | 2.36 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 5.86% | 4.29 | |
| 15 Sep 2020 | 5.88% | 5.29 | |
| 30 Sep 2020 | 11.52% | 4.84 | |
| 15 Oct 2020 | 12.26% | 11.55 | |
| 30 Oct 2020 | 14.45% | 10.43 | |
| 13 Nov 2020 | 13.88% | 9.97 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 13.48% | 12.03 | |
| 15 Dec 2020 | 13.38% | 12.77 | |
| 31 Dec 2020 | 12.81% | 6.60 |
See also: RIGEL PHARMACEUTICALS INC's full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.